• § 413.170 - Scope.

• § 413.171 - Definitions.

• § 413.172 - Principles of prospective payment.

• § 413.174 - Prospective rates for hospital-based and independent ESRD facilities.

• § 413.176 - Amount of payments.

• § 413.177 - Quality incentive program payment.

• § 413.178 - ESRD quality incentive program.

• § 413.180 - Procedures for requesting exceptions to payment rates.

• § 413.182 - Criteria for approval of exception requests.

• § 413.184 - Payment exception: Pediatric patient mix.

• § 413.186 - Payment exception: Self-dialysis training costs in pediatric facilities.

• § 413.194 - Appeals.

• § 413.195 - Limitation on Review.

• § 413.196 - Notification of changes in rate-setting methodologies and payment rates.

• § 413.198 - Recordkeeping and cost reporting requirements for outpatient maintenance dialysis.

• § 413.200 - [Reserved]

• § 413.202 - Organ procurement organization (OPO) cost for kidneys sent to foreign countries or transplanted in patients other than Medicare beneficiaries.

• § 413.203 - Transplant center costs for organs sent to foreign countries or transplanted in patients other than Medicare beneficiaries.

• § 413.210 - Conditions for payment under the end-stage renal disease (ESRD) prospective payment system.

• § 413.215 - Basis of payment.

• § 413.217 - Items and services included in the ESRD prospective payment system.

• § 413.220 - Methodology for calculating the per-treatment base rate under the ESRD prospective payment system effective January 1, 2011.

• § 413.230 - Determining the per treatment payment amount.

• § 413.231 - Adjustment for wages.

• § 413.232 - Low-volume adjustment.

• § 413.233 - Additional facility-level adjustments.

• § 413.234 - Drug designation process.

• § 413.235 - Patient-level adjustments.

• § 413.236 - Transitional add-on payment adjustment for new and innovative equipment and supplies.

• § 413.237 - Outliers.

• § 413.239 - Transition period.

• § 413.241 - Pharmacy arrangements.